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Abstract 
Introduction: Recently, radiofrequency ablation therapy (RFA) for liver tumors has been widely 
applied in clinical settings. In this study, the effect of radiofrequency ablation (RFA) on the 
intrahepatic vessels and bile ducts was examined experimentally and clinically based on the 
RFA principle of in resistance heating with an alternating current, as opposed to dielectric 
heating with electromagnetic waves and microwaves.  
Methods: The RF-Generator (Model 500, RITA Medical Systems, Inc., Mountain View, CA) 
was used for RFA. For in vitro and in vivo experiments, Japanese white rabbits and an adult 
dog were used.  
Results: Exp. 1. A constant output of RFA to the target tissues elevated the temperatures to 
100°C or higher in liver tissues, and ≤50°C in blood and bile. The impedances of the liver 
tissues, blood, and bile were 159 ± 33.0 Ω, 136 ± 20.7 Ω, and 73 ± 17.6 Ω, respectively. The 
tissues with the higher impedance showed a higher temperature elevation. Exp. 2. When RF 
output was applied to a series circuit formed by the liver tissues and blood, and to a series 
circuit formed by the liver tissues and bile, the voltage drop was highest in the liver tissues, 
followed by the blood and the bile. Exp. 3. In vivo, after the RF output was applied to adult dog 
livers, the temperature of the liver parenchyma was elevated while that of the intrahepatic bile 
ducts remained nearly consistent at 40°C. Exp. 4. RFA of the liver with hepatic blood flow 
occlusion by the Pringle maneuver resulted in a significantly higher temperature elevation 
compared with the liver without hepatic blood flow occlusion. Exp. 5. A rabbit liver was 
examined histologically 10 days after RFA. Within the RFA thermocoagulation area, 
obstruction and rupture were found in the bile ducts (≤25 µm in diameter) and portal veins (≤50 
µm in diameter). No abnormality was observed in larger bile ducts and vessels. Clinical data of 
RFA. The effect of RFA on the intrahepatic portal veins, veins, and bile ducts was examined 
using dynamic computed tomography (CT) images. In the portal veins, narrowing was 
observed in only 2 of 32 veins. No narrowing was found in the hepatic veins. In the intrahepatic 
bile ducts, no biloma and biliary dilatation due to bile duct rupture distal to the RFA-ablated 
area were observed.  
Discussion: According to Ohm’s law, when current I (ampere) flows between the puncture 
needle and counter electrode plates, and electric resistance is expressed as R (Ω), the calorific 
values of the tissues can be expressed as I2R (watts). The output needed for thermocoagulation 
of the liver tissues is often insufficient to warm the vessels and bile ducts despite RF resistance 
heating because of the low impedance of the blood or bile. The voltage drop in the blood or bile 
is also lower than in the liver parenchyma tissues. The electric workload as a source of heat is 
greatest in the liver tissues, followed by the blood, and bile. These properties make the blood 
and bile harder to warm up than the liver parenchyma tissues. These were verified by in vivo 
experiment with a dog. Therefore, RFA is a safe and less-invasive therapy for treatment of the 
intrahepatic vessels and bile ducts. 
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1. Introduction 
Systematic surgical resection is the first-line therapy for liver tumors. However, other therapies, 
including transarterial embolization (TAE), percutaneous ethanol injection (PEI), and 
microwave coagulation therapy (MCT), are often chosen depending on the patient’s overall 
status and tumor-related factors. Recently, radiofrequency ablation therapy (RFA) for liver 
tumors has been widely applied in the clinical setting. RFA cost has been covered by the health 
insurance in Japan since April 2004. In collaboration with United States-based ZoMed 
International, Inc. (currently RITA Medical Systems, Inc.), we initiated a fundamental research 
on the radiofrequency wave generator since October 1994. After ethical committee approval 
was obtained, RFA was implemented for the clinical treatment of liver tumors in October 1995, 
and the clinical outcomes were first reported in 1997 [1]. RFA output properties are mild, and it 
is an excellent method in which the temperature and coagulation range are adjusted easily. 
The effects of TAE are more likely to be affected by hemodynamics [2][3]. Although there are 
various effective PEI techniques, they are limited by the target tumor diameter [4]. RFA is not 
affected by these factors, and its therapeutic effects have been confirmed [5][6][7][8][9]. 
Although MCT is a thermocoagulation therapy similar to RFA, serious MCT-related 
complications such as portal vein injury, bile duct injury, liver abscess, biloma, and bleeding 
have been reported [10][11]. Although RFA has been established as the primary therapy for 
liver tumors, only a few basic research reports of RF wave use associated with liver tumor 
treatment exist. 
Among the wide range of RF wavelengths, 460 kHz is considered the medical RF frequency in 
Japan. This RF wave is identical to the frequency band used in electrical surgical knife. Here, 
the thermocoagulation treatment with RF waves was observed and characterized.  
The extent of RFA thermocoagulation was initially assessed with human albumin solution. 
Interestingly, thermocoagulation occurred only with microwave output, and not with RFA. This 
led us to further investigate the principles behind RFA and microwave thermocoagulation. 
Microwave coagulation occurs through dielectric heating while RFA involves resistance 
heating with an alternating current. We hypothesized that the electrical characteristics of a 
tissue determine the amount of energy in RFA thermocoagulation. Sometimes MCT-related 
complications such as injury to the intrahepatic bile ducts and vessels occur and pose clinical 
problems. Since albumin solutions (similar to the blood plasma flowing through the vessel) are 
not easily thermally coagulated by RFA, RFA is likely to be a safer treatment than MCT. 
Based on the RFA principle of resistance heating with an alternating current, not dielectric 
heating with electromagnetic waves and microwaves, we performed a fundamental examination 
on the effect of the unique heat-generating properties of resistance heating on tissues 
surrounding the tumor, particularly the clinically significant intrahepatic vessels and bile duct. 
 
2. Materials and Methods 
RFA device 
We used an RF-Generator (Model 500, RITA Medical Systems, Inc., Mountain View, CA) that 
can regulate RF waves with a frequency of 460 kHz every 0.2 W between outputs of 0−50 W to 
provide variable output frequencies for RFA. Its puncture electrode needle tip has 4−8 hooks 
with variable-lengths. A thermocouple temperature sensor is incorporated into each hook tip. 
The temperature of 4 independent places can be monitored on the screen of the device and a 
laptop computer. During RFA, the user maintains the appropriate temperature by adjusting the 
output while checking the temperature. 
In subsequent experiments, Japanese white rabbits were used. In experiments where a large 
liver was required for insertion of the thermocouple into the bile duct, an adult dog liver was 
used. 
The animal experiments were approved in accordance with the "Guide for Animal 
Experimentation, Inohana Campus, Chiba University (1991)" by the Special Committee on 
Animal Welfare of Inohana Campus, Chiba University. 
Experimental methods 
In the first experiment, we verified whether the electrical characteristics of individual tissues of 
bile, blood, and liver parenchyma  determine the amount of energy in RFA thermocoagulation 
or not. Next, each voltage drop in the series circuit formed by multiple tissues was measured as 
a thermocoagulation energy source. In experiments 3 and 4, increasing temperature in an in 
vivo liver by RFA, and the cooling effect of blood flow in the liver on the temperature increase 
by RFA were observed, respectively. Finally, histologic changes in rabbit livers after RFA were 
examined. 
 
Experiment 1. In vitro examination of heat-generating properties of RFA in the liver tissues 
To verify whether the electrical characteristics of tissues determine the amount of energy in 
RFA thermocoagulation or not, RFA was individually performed in bile, blood, and liver 
parenchyma obtained from Japanese white rabbits, and their heat generation properties were 
examined. A 25 cm long, 14-gauge monopolar puncture needle was used. Thirty grams each of 
liver tissues, blood, and bile were collected from ten Japanese white rabbits (Funabasi Farm Co., 
Ltd.), iced to 4°C, and initial temperatures were kept constant. Each tissue was placed in a 
beaker with counter electrode plates on the bottom. The hook length of the puncture needle was 
1 cm. RFA (10 W) was performed to the tissues for 5 minutes. The temperature change in each 
tissue was monitored using the temperature sensor of the hook tip. For impedance, the 
measured values between the puncture needle and the counter electrode plates were used. The 
precision was 0-120°C ± 2°C and 40-200 Ω ± 20%. 
 
Experiment 2. In vitro measurement of the voltage drop in the blood and bile 
In a series circuit formed by multiple tissues, each voltage drop becoming a thermocoagulation 
energy source was measured. The rabbit liver, blood, and bile were of equal volume. The in 
vitro state of the blood and bile in the liver was compared with the measured voltage and 
resistance levels after the RF wave was applied to blood, bile, and liver tissues in a series. Each 
voltage and resistance level of the liver, blood, and bile was measured when the RF wave (5 W) 
was applied to (1) the blood and the liver, and (2) the bile and the liver by using the RF 
Generator (Fig. 1). 
 
Experiment 3. In vivo measurement of temperature elevation in the liver tissues and bile ducts 
using liver RFA 
The increasing temperature by RFA was observed in vivo. The RFA puncture needle was 
inserted and fixed in an adult dog liver under general anesthesia. Then, the thermocouple was 
inserted into the bile ducts in the porta hepatis, through to the peripheral intrahepatic bile duct, 
and positioned in the bile duct 5 mm away from the tip of the RFA puncture needle implanted 
into the liver. Simultaneously, the thermocouple was placed in the liver parenchyma 5 mm 
away from the tip of the RFA puncture needle. RFA (10 W) was performed for 5 minutes. The 
temperature elevation in the bile ducts and liver parenchyma located at the same distance from 
the puncture needle were measured (Fig. 2). 
 
Experiment 4. Effect of blood flow on temperature elevation caused by liver RFA in vivo 
The cooling effect of blood flow in the liver on the temperature increase by RFA was observed. 
Ten Japanese white rabbits were used for this experiment. The entire hepatoduodenal ligament 
was clamped at the porta hepatis. RFA (10 W) was applied to the livers without (n = 5) and 
with (n = 5) hepatic blood flow occlusion by using the Pringle maneuver for 5 minutes. The 
temperature variation and ablation volume of the surface of the liver slice were measured. 
 
Experiment 5. Examination of the histologic changes in the intrahepatic bile ducts after RFA 
Histological examination of rabbit livers following RFA was conducted. RFA (10 W) was 
applied to the livers of Japanese white rabbits for 5 minutes. The livers were resected 10 days 
after RFA. Histopathology of the vessels and bile ducts stained with hematoxylin and eosin 
were assessed based on diameter and distance from the area of necrosis due to RFA. 
 
Clinical data of RFA 
The effect of RFA on the intrahepatic portal veins, hepatic veins, and intrahepatic bile ducts 
was examined by using clinical data. We examined 16 nodules in primary hepatocellular 
carcinoma after RFA. On dynamic computed tomography (CT), the diameter changes in the 
portal veins adjacent to the area of RFA ablation and in the hepatic veins were measured and 
examined according to the diameter and distance from the area of ablation (observation period 
after RFA, 1−9 months; mean, 4.7 ± 2.1 months). 
 
3. Results 
Experiment 1 
Under the same heating conditions, the temperature of the liver tissues was elevated to 100°C, 
whereas that of the blood and bile remained below 50°C (Fig. 3). The impedances of the liver 
tissues, blood, and the biliary ducts were 159 ± 33.0 Ω, 136 ± 20.7 Ω, and 73 ± 17.6 Ω, 
respectively (Fig. 4). 
 
Experiment 2  
For the liver and blood, the resistance values were 113.2 ± 19.2 Ω and 82.4 ± 3.9 Ω, and the 
voltage drops were 16.7 ± 1.9 V (effective value, shown hereafter) and 12.1 ± 0.8 V, 
respectively. For the liver and bile, the resistance values were 120.2 ± 18.7 Ω and 36.8 ± 3.5 Ω, 
and the voltage drops were 18.6 ± 2.2 V and 7.6 ± 2.1 V, respectively (Fig. 5). 
 
Experiment 3  
The temperature of the liver parenchyma was higher than 100°C at 1 minute after the RFA 
initiation, while that of the bile duct did not exceed 40°C even after 5 minutes (Fig. 6). 
 
Experiment 4  
Both temperature elevation and ablation volume were significantly higher in the livers with 
hepatic blood flow occlusion than in those without hepatic blood flow occlusion (Fig. 7 and Fig. 
8). 
 
Experiment 5 
Approximately 60% of the bile ducts with diameters of ≤25 µm showed obstruction and rupture 
within the ablation area, whereas patency was maintained in all bile ducts with diameters of 
≥25 µm and those located outside the thermocoagulation area. Similarly, approximately 60% of 
the intrahepatic portal veins with diameters of ≤50 µm showed obstruction and rupture within 
the ablation area, while patency was maintained in all bile ducts with diameters of ≥50 µm and 
those located outside the thermocoagulation area (Fig. 9 and Fig. 10). 
 
Clinical data of RFA 
The clinical effect of RFA on the intrahepatic portal veins, hepatic veins, and intrahepatic bile 
ducts was examined. In the portal veins, narrowing was observed in only 2 of 32 veins. No 
narrowing was found in the hepatic veins. In the cases of narrowing, the veins narrowed to 50% 
or less of their pre-RFA diameter. 
The intrahepatic bile duct diameter cannot be measured when it runs on the portal vein on CT. 
However, no biloma and biliary dilatation due to bile duct rupture distal to the RFA-ablated 
area was observed. Therefore, no stenosis or rupture of the bile ducts likely occurred in the 
ablation area (Table 1-a & b). 
Furthermore, the chronological observation of clinical data showed that the diameter change 
tended to be consistent 7 days after RFA both in the portal and hepatic veins in the ablation 
area (Fig. 11). 
 
4. Discussion 
In the liver electrical model, the liver parenchyma represents the mass with a relatively higher 
electrical resistance, while the blood vessels and bile ducts passing through the liver have a 
lower electrical resistance. According to Sakamoto [12], the intracellular and extracellular 
solution resistance varies widely depending on the tissues, but is approximately 50 Ω−2 kΩ, 
with a relative permittivity of 50-100, similar to that of water. For the electrical equivalent 
circuit, the electric capacity can be neglected if the frequency is within 1 kHz−10 MHz. Hence, 
only the electric resistance is considered when taking into account the heat generated by RFA, 
and the electric capacity can be neglected since the RF wave used in this study is an alternating 
current with a frequency of 460 kHz. According to Ohm’s law, when current I (ampere) flows 
between the puncture needle and counter electrode plates, and the electric resistance is 
expressed as R (Ω), the calorific values of the tissues can be expressed as I2R (watts),  
Around the puncture needle, the current density and the local heat generation are higher. In the 
area away from the puncture needle, the electric current spreads. In other words, the current I 
decreases and there is no heat generation, which can cause heat coagulation of the tissues. Of 
clinical significance, is the effect on relatively large blood vessels and bile ducts located around 
the puncture needle tip. No effect on the area outside the thermocoagulation range has been 
reported [13]. 
The impedances of the liver tissues, blood, and bile were 159 ± 33.0 Ω, 136 ± 20.7 Ω, and 73 ± 
17.6 Ω, respectively, which indicated that the calorific value was highest in the liver 
parenchyma tissues, followed by blood and bile. Thus, temperature elevation depends on the 
impedance, R. It is difficult to determine the site, direction, and volume of a flowing electric 
current in three-dimensional tissues. Our results showed that around the puncture needle, the 
temperature of the liver tissues was elevated to 100°C or more, while that of blood and bile did 
not exceed 50°C. The temperature may not have been elevated sufficiently to achieve 
thermocoagulation even with adequate quantities of bile and blood. 
Tissues with low impedances such as blood and bile had lower voltage drops than the liver 
parenchyma tissues. The blood to liver resistance and voltage ratios were nearly equal (0.80 
and 0.82, respectively) and the electric current was 0.147 ± 0.013 A and 0.149 ± 0.008 A, 
respectively. Furthermore, the calculated electric power involved in heat generation was 1.794 
± 0.193 W and 2.484 ± 0.239 W in the blood and liver, respectively. Similarly, the bile to liver 
resistance and voltage ratios were almost equal (0.30 and 0.27, respectively), although the 
voltage ratio was moderately lower than the resistance ratio, and the electric current was 0.206 
± 0.045 A and 0.156 ± 0.015 A, respectively. The calculated electric power involved in heat 
generation was 1.666 ± 0.811 W and 2.893 ± 0.389 W in the bile and the liver, respectively. 
The specific heat, heat conductivity, thermal diffusion, and other factors needed to calculate the 
actual temperature elevation level could not be determined. Therefore, the temperature ratio 
and temperature difference of each tissue were not identified by the calculated electric power. 
However, it is certain that the calculated electric power values, with their impedances and 
voltage drops, cause the differences in the heat source. 
The electric workload as a heat source may be greater in the liver, followed by the blood and 
bile, even if their volumes are the same. The human liver parenchyma accounted for the most 
volume between the puncture needle and counter electrode plates. Within the 
thermocoagulation area of 3 cm in diameter around the puncture needle, the blood and bile 
were scattered in the blood vessel and bile duct, respectively. We hypothesized that the voltage 
drop of the blood and bile was lower compared with their in vitro counterparts (experiment 2), 
and the voltage drop of the liver increased adversely. This was supported by results from 
experiment 3, closely related to clinical RFA, where temperature in the bile ducts was 
approximately 60°C lower than the temperature of the liver parenchyma. 
The liver has an abundant blood flow. The calorific values in the blood and bile were low, 
particularly in the blood vessels, and thermal diffusion due to blood flow inhibited the 
temperature elevation with RFA. Experiment 4 results showed that both the temperature 
elevation and ablation volume were greater in the livers with hepatic blood flow occlusion than 
in those without occlusion. Therefore, the effect of RFA on the blood flow was substantial. 
The electric resistance is inversely proportional to the cross section of the passing resistor and 
directly proportional to the length. Experiment 1 results revealed that the impedance in the 
presence of adequate quantities of blood and bile was lower than that of the liver parenchyma. 
The electric resistance in thin peripheral blood vessels and bile ducts is likely increased because 
the blood and bile are contained in the tube space. Thermal diffusion through the blood flow is 
also likely decreased. After RFA, obstruction and rupture occurred in the intrahepatic bile ducts 
with diameters of ≤25 µm and in intrahepatic portal veins with diameters of ≤50 µm. However, 
RFA had no effect on larger bile ducts, portal veins, and hepatic veins, which indicated that 
RFA was safe for the vessels and bile ducts. The chronological examination of the clinical data 
showed that there was a safe diameter of the bile ducts and vessels within the 
thermocoagulation area. RFA is a safe thermocoagulation therapy, and will unlikely result in 
serious complications such as portal vein injury, bile duct injury, liver abscess, biloma, and 
bleeding observed in MCT. 
 
5. Conclusion 
The RFA output for thermocoagulation of the liver and tumor tissues is insufficient to warm the 
vessels and bile ducts even with RF resistance heating because of low impedances of the blood 
and bile. Therefore, RFA is a safe, less-invasive therapy for intrahepatic vessels and bile ducts. 
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Fig. 1. Voltage drop in blood and bile.
(Radiofrequency (RFA) output: 5 W; resistance value and effective voltage of both A and B were 
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Fig. 3. Temperature increase on RF heating compared to rabbit liver tissue in vivo 
(RF output: 10 W, n = 10)
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Fig. 6. Temperature of the dog bile duct and liver tissue on RF heating in vitro 
(Mongrel dog liver, 10 W, 5 minutes)
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Fig 7. In vitro rabbit liver temperature elevation with and without Pringle 
maneuver and on RFA (RF output: 10 W, 5 minutes, n = 10)
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Fig. 8. Temperature elevation with and without Pringle maneuver and on RF 
ablation volume of the rabbit liver in vitro (length × width × height, RF output: 
10 W, 5 minutes, n = 10)
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Fig. 9. Distance from the RFA ablation area and in vitro changes in the 
intrahepatic bile duct (Japanese white rabbit normal liver, RFA 100°C, 5 
minutes, 10 days later)
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Fig. 10. Distance from the RFA ablation area and in vitro changes in the portal 
vein (Japanese white rabbit normal liver, RFA 100°C, 5 minutes, 10 days later)
Not 
different
Not 
different
Distance Total Narrowing Stability
Involved 4 0 (0%) 4 (100)
0 (mm) 10 1 (10) 9 (90)
>0, ≦10 13 0 (0) 13 (100)
>10, ≦20 5 1 (20) 4 (80)
Table 1-a. Changes in distance from the necrotic area on RFA and diameter of intrahepatic vessels 
(Between  October 1995 and March 1997, hepatocellular carcinoma, 16 nodules) 
Observation period: 1 to 9 months, mean: 4.7 ± 2.1 months. On dynamic computed tomography, the 
diameter changes in the intrahepatic portal veins and hepatic veins adjacent to the necrotic area by 
RFA were examined according to distance from the necrotic area.
(Criteria)
1. Involved group: 100% surrounded by the necrotic tissues.
2. Narrowing group: diameter was decreased by 50% or less than that before RFA.
Intrahepatic portal vein
Distance Total Narrowing Stability
Involved 1 0 (0%) 1 (100%)
0 (mm) 8 0 (0) 8 (100)
>0,≦10 3 0 (0) 3 (100)
>10, ≦20 1 0 (0) 1 (100)
Table 1-b. Changes in distance from the necrotic area on RFA and diameter of intrahepatic vessels 
(Between  October 1995 and March 1997, hepatocellular carcinoma, 16 nodules) 
Observation period: 1 to 9 months, mean: 4.7 ± 2.1 months. On dynamic computed tomography, the 
diameter changes in the intrahepatic portal veins and hepatic veins adjacent to the necrotic area by 
RFA were examined according to distance from the necrotic area.
(Criteria)
1. Involved group: 100% surrounded by the necrotic tissues.
2. Narrowing group: diameter was decreased by 50% or less than that before RFA.
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Fig.11. Changes in intrahepatic portal vein and hepatic vein diameter in the RFA 
ablation area (Between October 1995 and March 1997, hepatocellular 
carcinoma, 16 nodules)
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